Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Kawasaki disease].

D Floret1

  • 1Unité de réanimation pédiatrique, hôpital Edouard-Herriot, Lyon, France.

La Revue Du Praticien
|December 1, 1990
PubMed
Summary
This summary is machine-generated.

Kawasaki disease, an infectious illness primarily affecting children, presents with fever, rash, and inflammation. Early treatment with immunoglobulin and aspirin can prevent serious cardiac complications like coronary artery aneurysms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Vaccines and vaccination against human papillomaviruses in 2008].

Virologie (Montrouge, France)·2022
Same author

[The development of vaccination policy].

Revue des maladies respiratoires·2019
Same author

Survey of delivery of prophylactic immunoglobulins following exposure to a measles case.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2012
Same author

A report on the large measles outbreak in Lyon, France, 2010 to 2011.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2012
Same author

[Bulletin INFOVAC-France].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2011
Same author

Pediatric neurological complications associated with the A(H1N1)pdm09 influenza infection.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology·2011
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Rheumatology

Context:

  • Kawasaki disease, first identified in Japan in 1967, is a global health concern.
  • Primarily affecting infants and young children, its exact cause remains unknown despite extensive research.
  • The disease is characterized by a distinct set of clinical manifestations.

Purpose:

  • To summarize the key clinical and laboratory features of Kawasaki disease.
  • To highlight the significant cardiovascular risks associated with the condition.
  • To outline current treatment strategies and their impact on disease progression.

Summary:

  • Kawasaki disease presents with prolonged fever, conjunctivitis, oral/pharyngeal mucosal lesions, extremity changes, rash, and lymphadenopathy.
  • Laboratory findings typically include an inflammatory syndrome and thrombocytosis.

Related Experiment Videos

  • While generally self-limiting, the primary concern is cardiovascular involvement, particularly coronary artery aneurysms.

    • Impact:

    • Cardiovascular complications, such as coronary artery aneurysms, are the leading cause of mortality (1-2%).
    • Prompt treatment with intravenous immunoglobulin and aspirin is crucial.
    • Early intervention significantly reduces the risk of developing coronary artery aneurysms, improving patient outcomes.